AKT1 and postmenopausal osteoporosis: As the progressive bone loss in postmenopausal osteoporosis is mainly due to overactivation of osteoclast (Eastell et al., 2016), ZG may inhibit osteoblastic bone resorption via predicted the PI3K/Akt pathway.